6725 studies found for:    "Growth Substances"
Show Display Options
Download search resultsDownload the search results for:
"Growth Substances" (6725 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective
Conditions: Metastatic Hepatocellular Carcinoma;   Advanced Liver Cancer
Interventions: Drug: Ascorbic Acid + Sorafenib;   Drug: Sorafenib alone
2 Recruiting Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca
Condition: Stage IV Pancreatic Cancer
Intervention: Drug: Ascorbic Acid
3 Terminated Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA
Condition: Stage IV Colorectal Cancer
Intervention: Drug: Vitamin C
4 Terminated Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors
Conditions: Neuroendocrine Tumors;   Pancreatic Neoplasms;   Advanced Disease;   Sunitinib
Intervention: Drug: Sutent
5 Terminated Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma
Conditions: Hepatocellular Carcinoma;   Fibrolamellar Hepatocellular Carcinoma
Intervention: Drug: Sutent
6 Completed Trial of Vitamin D Supplementation for the Prevention of Influenza and Other Respiratory Infections (ViDiFlu)
Conditions: Respiratory Tract Infections;   Influenza
Interventions: Dietary Supplement: Cholecalciferol (Vitamin D/Vigantol oil);   Dietary Supplement: Miglyol oil
7 Terminated Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma Non-resectable;   Hepatocellular Carcinoma Recurrent;   Carcinoma, Hepatocellular;   Liver Diseases;   Neoplasms by Histologic Type;   Digestive System Neoplasms;   Carcinoma;   Liver Neoplasms;   Neoplasms;   Neoplasms by Site;   Digestive System Diseases;   Adenocarcinoma;   Neoplasms, Glandular and Epithelial
Interventions: Drug: ABT-869;   Drug: Sorafenib
8 Completed Patellar Tendon Regeneration With Platelet-rich Plasma
Condition: Knee Instability
Interventions: Procedure: Platelet-rich plasma;   Procedure: Control group
9 Terminated Growth Hormone and Heart Failure
Condition: Heart Failure, Congestive
Intervention:
10 Completed A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy
Conditions: HIV Infections;   Peripheral Nervous System Disease
Intervention: Drug: Nerve Growth Factor, Recombinant Human
11 Not yet recruiting Promoting Physical Growth and Positive Development in Severely Stunted Guatemalan Children
Conditions: Malnutrition;   Developmental Disabilities
Interventions: Behavioral: Home-based nutrition education;   Dietary Supplement: Standard-of-care nutrition support
12 Not yet recruiting Trial of Vitamin D3 Supplementation in Paediatric Autism
Condition: Autism
Interventions: Dietary Supplement: Vitamin D3;   Dietary Supplement: Placebo
13 Not yet recruiting FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer
Conditions: Recurrent Colorectal Carcinoma;   Stage IVA Colorectal Cancer;   Stage IVB Colorectal Cancer
Interventions: Drug: Fluorouracil;   Drug: Irinotecan Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Biological: Panitumumab
14 Recruiting Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis
Condition: Bronchiectasis
Interventions: Drug: Cholecalciferol;   Drug: Placebo
15 Active, not recruiting Adapted Fluence Settings for Corneal Collagen Cross-linking in Mild to Moderate Progressive Keratoconus
Condition: Keratoconus
Interventions: Radiation: adjusted corneal collagen cross-linking;   Radiation: accelerated corneal collagen cross-linking;   Drug: riboflavin 0.1% combined with dextran 20 %;   Procedure: epithelial debridement
16 Not yet recruiting Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165
Conditions: Mantle Cell Lymphoma;   Non-Hodgkin's Lymphoma
Interventions: Drug: Thalidomide;   Other: Clinical/Laboratory Evaluations;   Other: Survival
17 Not yet recruiting Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Busulfan;   Drug: Palifermin;   Drug: Panobinostat;   Drug: Gemcitabine;   Drug: Melphalan;   Drug: Dexamethasone acetate;   Drug: Caphosol;   Drug: Glutamine;   Drug: Pyridoxine;   Procedure: Stem Cell Transplant
18 Recruiting Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection
Conditions: Stage ⅠA Pancreatic Cancer;   Stage ⅠB Pancreatic Cancer;   Stage ⅡA Pancreatic Cancer;   Stage ⅡB Pancreatic Cancer
Interventions: Drug: nab-paclitaxel;   Drug: gemcitabine;   Drug: oxaliplatin;   Drug: folinic acid;   Drug: fluorouracil
19 Recruiting Nutritional Requirements for Vitamin D in Pregnant Women
Condition: Vitamin D Deficiency
Interventions: Dietary Supplement: 10 mcg Vitamin D3;   Dietary Supplement: 20 mcg Vitamin D3;   Dietary Supplement: Placebo
20 Not yet recruiting The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome
Conditions: Graft vs Host Disease;   Allogeneic Hematopoietic Cell Transplantation;   Mucositis
Interventions: Drug: Folinic acid;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years